文献速递甲状腺与浅表头颈介入US

最初按良性行射频消融治疗的甲状腺结节延迟诊断为癌:超声特征与癌的预测因素

Delayed Cancer Diagnosis in Thyroid Nodules Initially Treated as Benign With Radiofrequency Ablation: Ultrasound Characteristics and Predictors for Cancer.
PubMed 文献 · Korean J Radiol · 2023-01-01

回顾性分析134例患者148个超声引导活检诊断为良性、因有症状行射频消融减瘤的甲状腺结节,36个(24.3%)再生长,手术切除22个,确诊恶性7个(占36个的19.4%);恶性结节消融前体积更大、12个月体积缩小率更低,作者认为再生长或缩小不佳者需警惕恶性,用粗针活检确认优于细针穿刺。

要点

  • 消融前体积更大(恶性中位22.4 mL vs 良性13.4 mL,P=0.04)与12个月缩小率更低(51.4% vs 83.8%,P=0.01)提示恶性可能。
  • 148个良性结节射频消融后再生长36个(24.3%),其中手术22个、确诊恶性7个(占36个的19.4%)。
  • 再生长恶性结节粗针活检均诊断为可疑滤泡性肿瘤,作者认为粗针活检确认优于细针穿刺。

核心结论

  • 有症状的大型良性甲状腺结节射频消融后再生长或缩小不充分可能具有恶性潜能,作者认为用粗针活检确认这些结节优于细针穿刺。

研究设计与样本

  • 回顾性研究,纳入2008年2月至2016年11月间因有症状、经超声引导活检诊断为良性而行射频消融减瘤的134例连续患者共148个结节,参考标准为最终手术病理。

关键影像表现/征象

  • 射频消融后再生长见于148个良性结节中的36个(24.3%)。
  • 36个再生长结节中22个手术切除,7个确诊恶性(占36个的19.4%)。
  • 22个手术切除结节中,恶性结节消融前中位体积22.4 mL(范围13.9-84.5)大于良性结节13.4 mL(范围7.3-16.8),P=0.04。
  • 恶性与良性结节的再生长间隔无显著差异(P=0.49)。
  • 恶性结节12个月中位体积缩小率51.4%(范围0-57.8)低于良性结节83.8%(范围47.9-89.6),P=0.01。

诊断标准与关键数值

  • 消融前中位体积:恶性结节22.4 mL(范围13.9-84.5)vs 良性结节13.4 mL(范围7.3-16.8),P=0.04。
  • 12个月中位体积缩小率:恶性结节51.4%(范围0-57.8)vs 良性结节83.8%(范围47.9-89.6),P=0.01。
  • 再生长间隔在恶性与良性结节间无显著差异(P=0.49)。

临床应用与阅片要点

  • 作者认为,有症状的大型良性甲状腺结节射频消融后再生长或缩小不充分可能具有恶性潜能。
  • 作者认为,确认这些结节用粗针活检优于细针穿刺。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Regrowth after radiofrequency ablation (RFA) of symptomatic large thyroid nodules, initially treated as benign, sometimes turns out to be malignancies. This study aimed to assess the ultrasound (US) characteristics of thyroid nodules initially treated as benign with RFA and later diagnosed as cancers, predictive factors for cancers masquerading as benign, and methods to avoid RFA in these cancers.

MATERIALS AND METHODS: We reviewed the medical records of 134 consecutive patients with 148 nodules who underwent RFA between February 2008 and November 2016 for the debulking of symptomatic thyroid nodules diagnosed as benign using US-guided biopsy. We investigated the pre-RFA characteristics of the thyroid nodules, changes at follow-up after RFA, and the final surgical pathology.

RESULTS: Nodule regrowth after RFA was observed in 36 (24.3%) of the 148 benign nodules. Twenty-two of the 36 nodules were surgically removed, and malignancies were confirmed in seven (19.4% of 36). Of the 22 nodules removed surgically, pre-RFA median volume (range) was significantly larger for malignant nodules than for benign nodules: 22.4 (13.9-84.5) vs. 13.4 (7.3-16.8) mL (P = 0.04). There was no significant difference in the regrowth interval between benign and malignant nodules (P = 0.49). The median volume reduction rate (range) at 12 months was significantly lower for malignant nodules than for benign nodules (51.4% [0-57.8] vs. 83.8% [47.9-89.6]) (P = 0.01). The pre-RFA benignity of all seven malignant nodules was confirmed using two US-guided fine-needle aspirations (FNAs), except for one nodule, which was confirmed using US-guided core-needle biopsy (CNB). Regrown malignant nodules were diagnosed as suspicious follicular neoplasms by CNB. Histological examination of the malignant nodules revealed follicular thyroid carcinomas, except for one follicular variant, a papillary thyroid carcinoma.

CONCLUSION: Symptomatic large benign thyroid nodules showing regrowth or suboptimal reduction after RFA may have malignant potential. The confirmation of these nodules is better with CNB than with FNA.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Kim MK, Shin JH, Hahn SY, et al. Delayed Cancer Diagnosis in Thyroid Nodules Initially Treated as Benign With Radiofrequency Ablation: Ultrasound Characteristics and Predictors for Cancer. Korean J Radiol. 2023. PMID: 37634644. doi:10.3348/kjr.2023.0386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。